Therapeutic Area | MeSH |
---|---|
skin and connective tissue diseases | D017437 |
immune system diseases | D007154 |
Brand Name | Status | Last Update |
---|---|---|
cellcept | New Drug Application | 2025-05-19 |
mycophenolate mofetil | ANDA | 2025-08-02 |
mycophenolic acid | ANDA | 2025-07-23 |
myfortic | New Drug Application | 2025-06-27 |
myhibbin | New Drug Application | 2025-07-30 |
Code | Description |
---|---|
J7518 | Mycophenolic acid, oral, 180 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney transplantation | D016030 | — | — | 2 | 2 | 6 | 11 | 5 | 25 |
Heart transplantation | D016027 | EFO_0010673 | — | — | — | 1 | 4 | 2 | 7 |
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 3 | 2 | 2 | — | 6 |
Liver transplantation | D016031 | EFO_0010682 | — | — | 1 | — | 4 | — | 5 |
Renal insufficiency | D051437 | — | N19 | — | 1 | — | 1 | 2 | 4 |
Polyomavirus infections | D027601 | EFO_0007451 | — | — | — | — | 1 | — | 1 |
Corneal transplantation | D016039 | EFO_0010676 | — | — | — | — | 1 | — | 1 |
Delayed graft function | D051799 | — | — | — | — | — | 1 | — | 1 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | — | 1 | — | 1 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lupus nephritis | D008181 | EFO_0005761 | — | — | 2 | 5 | — | — | 7 |
Nephritis | D009393 | — | N05 | — | 2 | 5 | — | — | 7 |
Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | — | — | 3 | — | — | 3 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 1 | 1 | — | — | 2 |
Neuromyelitis optica | D009471 | EFO_0004256 | G36.0 | — | — | 2 | — | — | 2 |
Pemphigus | D010392 | EFO_1000749 | L10 | — | — | 2 | — | — | 2 |
Myasthenia gravis | D009157 | EFO_0004991 | G70.0 | — | — | 2 | — | — | 2 |
Muscle weakness | D018908 | — | — | — | — | 2 | — | — | 2 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 1 | 1 | — | — | 2 |
Glomerulonephritis | D005921 | — | N05 | — | 2 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | 1 | — | — | 3 | 4 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | 1 | 2 |
Localized scleroderma | D012594 | EFO_1001361 | L94.0 | — | 1 | — | — | 1 | 2 |
Diffuse scleroderma | D045743 | EFO_0000404 | — | — | 1 | — | — | 1 | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 1 | — | — | — | 1 |
Preleukemia | D011289 | — | — | — | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | — | 1 | — | — | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 1 | — | — | — | 1 |
Hypoglycemia | D007003 | — | E16.2 | 1 | 1 | — | — | — | 1 |
Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Immunosuppression therapy | D007165 | — | — | 1 | — | — | — | 1 | 2 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Vasculitis | D014657 | EFO_0006803 | M31 | 1 | — | — | — | — | 1 |
Microscopic polyangiitis | D055953 | EFO_1000784 | M31.7 | 1 | — | — | — | — | 1 |
Systemic vasculitis | D056647 | — | — | 1 | — | — | — | — | 1 |
Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | 1 | — | — | — | — | 1 |
Urologic diseases | D014570 | — | N39.9 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Graft vs host disease | D006086 | — | D89.81 | — | — | — | — | 1 | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Mycophenolic acid |
INN | mycophenolic acid |
Description | Mycophenolic acid is a member of the class of 2-benzofurans that is 2-benzofuran-1(3H)-one which is substituted at positions 4, 5, 6, and 7 by methyl, methoxy, (2E)-5-carboxy-3-methylpent-2-en-1-yl, and hydroxy groups, respectively. It is an antibiotic produced by Penicillium brevi-compactum, P. stoloniferum, P. echinulatum and related species. An immunosuppressant, it is widely used (partiularly as its sodium salt and as the 2-(morpholin-4-yl)ethyl ester prodrug, mycophenolate mofetil) to prevent tissue rejection following organ transplants and for the treatment of certain autoimmune diseases. It has a role as an antineoplastic agent, an antimicrobial agent, an EC 1.1.1.205 (IMP dehydrogenase) inhibitor, an immunosuppressive agent, a mycotoxin, a Penicillium metabolite, an environmental contaminant, a xenobiotic and an anticoronaviral agent. It is a gamma-lactone, a member of phenols, a monocarboxylic acid and a member of 2-benzofurans. It is functionally related to a hex-4-enoic acid. It is a conjugate acid of a mycophenolate. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2 |
PDB | — |
CAS-ID | 24280-93-1 |
RxCUI | — |
ChEMBL ID | CHEMBL866 |
ChEBI ID | 168396 |
PubChem CID | 446541 |
DrugBank | DB01024 |
UNII ID | HU9DX48N0T (ChemIDplus, GSRS) |